Dennis B. Costello
Direttore/Membro del Consiglio presso CardioPolymers, Inc.
Profilo
Dennis B.
Costello
Dennis is co-founder and Managing Partner of Triathlon Medical Ventures in Cincinnati.
Dennis brings more than 30 years of industry experience in both therapeutics and medical devices to Triathlon.
Dennis was with Senmed Medical Ventures from 1996 to 2003 where he originated and managed early and later-stage investments and provided general management for Senmed's start-up investments.
Prior to joining Senmed in 1996, he served in general management and senior marketing and business development positions for both large public and small private life science companies including American Critical Care (a division of American Hospital Supply Corporation), Clonetics Inc, Regent Hospital Products and Hana Biologics.
Dennis holds a BS from the U.S.
Naval Academy and an MBA from The Harvard Business School.
Posizioni attive di Dennis B. Costello
| Società | Posizione | Inizio |
|---|---|---|
CardioPolymers, Inc.
 CardioPolymers, Inc. Pharmaceuticals: MajorHealth Technology CardioPolymers, Inc. provides novel biocompatible polymer implant therapies to treat cronic heart failures. The company was founded in 2003 and is headquartered in Laguna Hills, CA. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Dennis B. Costello
| Società | Posizione | Fine |
|---|---|---|
Triathlon Medical Venture Partners LLC
 Triathlon Medical Venture Partners LLC Investment ManagersFinance Triathlon Medical Venture Partners LLC (Triathlon Medical Venture) is a venture capital firm founded in 2004 by Dennis Costello and John Rice. The firm is headquartered in Cincinnati, Ohio with additional offices in Indianapolis and Louisville. | Fondatore | 05/11/2014 |
| Senmed Medical Ventures | Corporate Officer/Principal | 01/01/2003 |
| American Hospital Supply Corp. | Corporate Officer/Principal | - |
Somatix Therapy Corp.
 Somatix Therapy Corp. BiotechnologyHealth Technology Somatix Therapy Corp. researches, develops, and commercialize proprietary processes for the genetic modification of cells and their use in the treatment of human disease. Somatix's assets include its highly efficient gene transfer technology, broad-based intellectual property, and focused product development programs. The company's most advanced clinical development program, the GVAX cancer vaccine, is in Phase I/II clinical trials for the treatment of metastatic renal cell carcinoma, advanced melanoma, and prostate cancer. It is located in Alameda, CA | Corporate Officer/Principal | - |
Clonetics Corp.
 Clonetics Corp. Medical SpecialtiesHealth Technology Part of Lonza Group AG, Clonetics Corp. supplies normal human cell systems. The company is based in San Diego, CA. The company was founded by Jeffrey D. Janus. Clonetics was acquired by Lonza Walkersville, Inc., part of Lonza Group AG from February 28, 2002 on January 18, 1996 for $8.80 million. | Corporate Officer/Principal | - |
Formazione di Dennis B. Costello
| United States Naval Academy | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Somatix Therapy Corp.
Somatix Therapy Corp. BiotechnologyHealth Technology Somatix Therapy Corp. researches, develops, and commercialize proprietary processes for the genetic modification of cells and their use in the treatment of human disease. Somatix's assets include its highly efficient gene transfer technology, broad-based intellectual property, and focused product development programs. The company's most advanced clinical development program, the GVAX cancer vaccine, is in Phase I/II clinical trials for the treatment of metastatic renal cell carcinoma, advanced melanoma, and prostate cancer. It is located in Alameda, CA | Health Technology |
HydroCision, Inc.
 HydroCision, Inc. Medical SpecialtiesHealth Technology HydroCision, Inc. develops, manufactures and markets fluid-jet based surgical tools. Its products include spinejet system, spinejet XL, hydrodiscectomy system and allograft system. The company was founded by Kevin P. Staid and Timothy E. Moutafis in 1994 and is headquartered in North Billerica, MA. | Health Technology |
| American Hospital Supply Corp. | Health Technology |
Clonetics Corp.
Clonetics Corp. Medical SpecialtiesHealth Technology Part of Lonza Group AG, Clonetics Corp. supplies normal human cell systems. The company is based in San Diego, CA. The company was founded by Jeffrey D. Janus. Clonetics was acquired by Lonza Walkersville, Inc., part of Lonza Group AG from February 28, 2002 on January 18, 1996 for $8.80 million. | Health Technology |
SuturTek, Inc.
 SuturTek, Inc. Medical SpecialtiesHealth Technology SuturTek, Inc. develops and manufactures needle-protected suturing devices. It offers reusable close devices which hold disposable cartridges preloaded with curved needles. The company was founded Gerald I. Brecher and John C. Meade in 1993 by and is headquartered in North Chelmsford, MA. | Health Technology |
| Senmed Medical Ventures | Finance |
Triathlon Medical Venture Partners LLC
Triathlon Medical Venture Partners LLC Investment ManagersFinance Triathlon Medical Venture Partners LLC (Triathlon Medical Venture) is a venture capital firm founded in 2004 by Dennis Costello and John Rice. The firm is headquartered in Cincinnati, Ohio with additional offices in Indianapolis and Louisville. | Finance |
CardioPolymers, Inc.
CardioPolymers, Inc. Pharmaceuticals: MajorHealth Technology CardioPolymers, Inc. provides novel biocompatible polymer implant therapies to treat cronic heart failures. The company was founded in 2003 and is headquartered in Laguna Hills, CA. | Health Technology |
- Borsa valori
- Insiders
- Dennis B. Costello
